Mateon Therapeutics (MATN) Announces Receipt of Cathepsin-Related U.S. Patent
Go back to Mateon Therapeutics (MATN) Announces Receipt of Cathepsin-Related U.S. Patent(AMEX: MATN) | Delayed: 0.26 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.26 | 52 Week High | $0.85 | |||
Open | $2.09 | 52 Week Low | $0.45 | |||
Day High | $0.26 | P/E | N/A | |||
Day Low | $0.26 | EPS | $0.00 | |||
Volume | 233,356 |